Complete Response Letters

Almatica Pharma, LLC: zolpidem tartrate

What FDA's Complete Response Letters to the company say, in the letters' own words.

EphemerisX Research · Sep 30, 2026 · Sources: FDA, SEC

Complete Response Letter, Jan 13, 2023

Drug, and Cosmetic Act for zolpidem tartrate capsules.

Complete Response Letter · Jan 13, 2023 · p. 2Open the letter at p. 2 ↗CRL_NDA215721_20230113:p1:s11

Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.